• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Section Contents Menu

News & Events

FDA Extends Comment Period on Proposed Rules for Foreign Supplier Verification Programs (FSVPs) and Accreditation of Third-Party Auditors/Certification Bodies

Food Basket

Center for Food Safety and Applied Nutrition - Food and Drug Administration

November 19, 2013

The U.S. Food and Drug Administration (FDA) is extending the comment period on two proposed rules: “Foreign Supplier Verification Programs for Importers of Food for Humans and Animals” (FSVPs) and “Accreditation of Third-Party Auditors/Certification Bodies to Conduct Food Safety Audits and to Issue Certifications” (Third-Party) that appeared in the July 29, 2013 Federal Register. Comments on these two proposed rules as well as comments on the information collection provisions associated with these rules may be submitted until January 27, 2014. Comments were originally due by November 26, 2013.

FDA is taking this action in response to requests for an extension to allow interested persons an opportunity to consider the interrelationship between these two proposed rules and the proposed rule announced in October 2013, “Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals.”

Submit comments on the proposed rules electronically at http://www.regulations.gov, using the Agency name and docket number FDA-2011-N-0143 (FSVPs) or FDA-2011-N-0146 (Third-Party).

To submit comments on the proposed rules by mail, send to:
Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
Comments should be identified with the docket number.

Submit comments electronically on the information collection to oira_submission@omb.eop.gov. Comments should be identified with the title of the appropriate proposed rule. 

Written comments on the information collection may also be faxed to: Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285. Comments should be identified with the title of the appropriate proposed rule.

For more information: